Core Laboratories Inc

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Core Labs reports strong Q4 performance, eyes growth opportunities

Core Laboratories Inc delivered a solid performance in Q4 2022, focusing on financial strength, operational efficiency, and future growth prospects. Despite facing challenges from external factors, the company remains optimistic about opportunities in the energy sector and its ability to create value for shareholders.

Core Laboratories Inc reports robust Q1 earnings, eyes EOR opportunities

Core Laboratories Inc delivered strong financial results, highlighted operational efficiencies, and outlined growth strategies amidst industry challenges. The company's focus on innovation, debt reduction, and cost savings bodes well for future performance and shareholder value.

Core Labs reports solid Q2 performance, eyes international growth

Core Laboratories Inc showcased strong financial performance in Q2 2023, with a focus on operational efficiency and technological advancement.
The company's commitment to maximizing free cash flow, returns on invested capital, and shareholder value underscores its financial discipline and strategic priorities.
Despite challenges in the US land sector, Core Labs remains optimistic about international growth opportunities and technological advancements driving future success.

Core Laboratories Inc reports strong Q3 performance amidst market challenges

Core Laboratories Inc delivered a strong Q3 performance with improvements in key financial metrics. While facing challenges in certain segments, the company's strategic focus on innovation and efficiency positions it well for future opportunities. Core Labs remains optimistic about its outlook and is committed to driving growth and value for shareholders.

Core Laboratories reports steady Q4 performance amidst operational challenges

Core Laboratories navigated challenges in Q4 with a focus on debt reduction, innovation, and operational excellence, showcasing resilience and adaptability.
While facing headwinds in certain segments, Core Labs remains committed to long-term sustainability, shareholder value, and technological advancement.
Strategic initiatives and operational highlights underscore Core's leadership in the industry, setting the stage for future growth and market expansion.

Core Labs maintains steady performance amidst geopolitical challenges and debt reduction

Core Laboratories Inc delivered a resilient performance in Q1 2024, focusing on operational efficiency and debt reduction amidst external challenges.
The company's strategic strengths lie in international growth prospects, technology investments, and commitment to financial stability.
Challenges from geopolitical conflicts and operational disruptions highlight the need for adaptability and diversification in Core Labs' business approach.
Opportunities abound in capitalizing on international growth, technology advancements, and maximizing return on invested capital for sustainable growth.

Core Laboratories reports revenue growth and debt reduction in Q3

Core Laboratories Inc delivered a solid financial performance in Q3 2024, with revenue growth, improved margins, and reduced debt levels.
While facing challenges in a competitive market and capital expenditure constraints, the company remains focused on sustaining profitability and operational efficiency.
Opportunities lie in leveraging segment revenue growth, debt reduction strategies, and exploring new avenues for expansion and partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Core Laboratories did not meet net sales expectations in the last quarter, but the outlook for international exploration recovery is positive. Demand for reservoir description services is increasing due to automation and digitalization. There are risks from supply chain disruptions, lower exploration investments, and stock price volatility, but the stock may trade at a higher price.

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

Core Laboratories (CLB) anticipates revenues in the range of $125-$132 million and operating income in the band of $13.8-$17.3 million for the fourth quarter of 2023. It also expects earnings per share in the 17-23 cents range.

Core Laboratories (CLB) Q3 Earnings Top, Revenues Miss

Core Laboratories Inc. (NYSE:CLB ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Gwen Gresham - Senior Vice President, Corporate Development & Investor Relations Larry Bruno - Chairman of the Board, Chief Executive Officer and President Chris Hill - Senior Vice President, Chief Financial Officer Conference Call Participants Operator Good day and welcome to the Core Laboratories Third Quarter 2023 Earnings Conference Call. [Operator instructions] After today's presentation, there will be an opportunity to ask questions.

Core Laboratories Inc. (CLB) Q3 2023 Earnings Call Transcript

Although the revenue and EPS for Core Laboratories (CLB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Core Laboratories (CLB) Reports Q3 Earnings: What Key Metrics Have to Say

REVENUE OF $125.3 MILLION; DOWN 2% SEQUENTIALLY; FLAT YEAR-OVER-YEAR OPERATING INCOME OF $14.7 MILLION; EX-ITEMS, $16.0 MILLION, UP OVER 2% SEQUENTIALLY; UP 20% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 13% GAAP EPS OF $0.19; EX-ITEMS, $0.22, UP 5% SEQUENTIALLY; UP 24% YEAR-OVER-YEAR RESERVOIR DESCRIPTION OPERATING MARGINS, EX-ITEMS, OF 17%; INCREMENTAL MARGINS EXCEEDING 100% SEQUENTIALLY; EXCEEDING 90% YEAR-OVER-YEAR COMPANY ANNOUNCES STRATEGIC DIGITAL ROCK CHARACTERIZATION ALLIANCE WITH HALLIBURTON COMPANY ANNOUNCES Q4 2023 QUARTERLY DIVIDEND HOUSTON ,  Nov. 1, 2023 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2023 revenue of $125,300,000. Core's operating income was $14,700,000, with diluted earnings per share ("EPS") of $0.19, all in accordance with U.S. generally accepted accounting principles ("GAAP").

CORE LAB REPORTS THIRD QUARTER 2023 RESULTS

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth

Halliburton

HOUSTON , Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of cutting-edge comprehensive digital rock data solutions from months to weeks, even while full petrophysical laboratory measurements are in progress. This collaboration combines Core Lab's industry-leading expertise in reservoir description and optimization technologies with Halliburton's specialization in pore-scale digital rock analysis.

CORE LABORATORIES AND HALLIBURTON ANNOUNCE COLLABORATION TO INTEGRATE DIGITAL ROCK CAPABILITIES WITH LABORATORY MEASURED DATA

HOUSTON, Oct. 2, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will broadcast its third quarter 2023 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m. EDT on November 2, 2023.

CORE LABORATORIES' THIRD QUARTER 2023 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M.

Matador Resources

Pioneer Natural Resources

Crude price is now in its glorious days, calling for investment in energy companies like Matador Resources (MTDR), Pioneer Natural (PXD) and Core Laboratories (CLB).

Oil Price Highest in More Than a Year: Bet on These 3 Stocks

Helix Energy Solutions Group

Solaris Oilfield Infrastructure

Crude price is now in its glorious days, calling for investment in oilfield service companies like Core Laboratories (CLB), Solaris Oilfield (SOI) and Helix Energy (HLX).

Play the 10-Month High Crude Price With These 3 Oilfield Stocks

Evolution Petroleum

The decisions of Saudi Arabia & Russia to voluntarily extend oil cuts until the year-end are aiding the crude rally. Solaris (SOI), Core Lab (CLB) and Evolution (EPM) are thus well-poised to gain.

Tap the Crude Rally With These Three Promising Energy Stocks

Schlumberger

With the expectations that crude prices will remain solid, demand for oilfield services will stay strong, making the outlook for the Zacks Oil & Gas- Field Services industry bright. SLB, HAL, CLB and SOI are expected to benefit the most from this.

4 Oilfield Services Stocks to Gain From the Prospering Industry

CVR Energy

Profire Energy

Many energy companies are witnessing upward earnings estimate revisions. Three such companies are Core Laboratories Inc. (CLB), Profire Energy, Inc. (PFIE) and CVR Energy (CVI).

3 Energy Stocks With Positive Earnings Estimate Revisions

Core Laboratories (CLB) anticipates revenues and operating income in the range of $128-$132 million and $15.2-$17.5 million, respectively, with earnings in the band of 21-25 cents per share for Q3 2023.

Core Laboratories (CLB) Q2 Earnings Top, Revenues Miss

The headline numbers for Core Laboratories (CLB) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Core Laboratories (CLB) Q2 Earnings: A Look at Key Metrics

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.12 per share a year ago.

Core Laboratories (CLB) Tops Q2 Earnings Estimates

REVENUE OF $127.9 MILLION; FLAT SEQUENTIALLY; UP 6% YEAR-OVER-YEAR OPERATING INCOME OF $18.9 MILLION; EX-ITEMS, $15.6 MILLION, UP 8% SEQUENTIALLY; UP OVER 60% YEAR-OVER-YEAR OPERATING MARGINS OF 15%; EX-ITEMS, OVER 12%, WITH YEAR-OVER-YEAR INCREMENTAL MARGINS EXCEEDING 85% GAAP EPS OF $0.48; EX-ITEMS, $0.21, UP 12% SEQUENTIALLY; UP 80% YEAR-OVER-YEAR RESERVOIR DESCRIPTION INCREMENTAL MARGINS, EX-ITEMS, EXCEEDING 100% SEQUENTIALLY; EXCEEDING 80% YEAR-OVER-YEAR FREE CASH FLOW OF $6.6 MILLION AT-THE-MARKET EQUITY OFFERING PROGRAM TERMINATED COMPANY ANNOUNCES Q3 2023 QUARTERLY DIVIDEND HOUSTON , July 26, 2023 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2023 revenue of $127,900,000. Core's operating income was $18,900,000, with diluted earnings per share ("EPS") of $0.48, all in accordance with U.S. generally accepted accounting principles ("GAAP").

CORE LAB REPORTS SECOND QUARTER 2023 RESULTS

Core Laboratories (CLB) Earnings Expected to Grow: Should You Buy?

HOUSTON , June 27, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will broadcast its second quarter 2023 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m.

CORE LABORATORIES' SECOND QUARTER 2023 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M.

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Core Laboratories (CLB) Up 1.4% Since Last Earnings Report: Can It Continue?

Business is improving for Core Laboratories Inc. at a very modest incremental pace. The company lacks a moat or a near-term catalyst.

Core Laboratories: Green Shoots, But Too Far Down The Road

Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.

Core Labs (CLB) Q1 Earnings & Sales Beat Estimates

Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript.

Core Laboratories N.V. (CLB) Q1 2023 Earnings Call Transcript

Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.08 per share a year ago.

Core Laboratories (CLB) Q1 Earnings and Revenues Surpass Estimates

REVENUE OF $128 MILLION; UP SLIGHTLY SEQUENTIALLY; UP 11% YEAR-OVER-YEAR OPERATING INCOME OF $6.5 MILLION; EX-ITEMS OF $14.5 MILLION, FLAT SEQUENTIALLY; UP OVER 100% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 11%, WITH YEAR-OVER-YEAR INCREMENTAL MARGINS EXCEEDING 55% GAAP EPS OF $0.05; EX-ITEMS, $0.19; UP OVER 130% YEAR-OVER-YEAR RESERVOIR DESCRIPTION INCREMENTAL MARGINS, EX-ITEMS, EXCEEDING 80% SEQUENTIALLY; 70% YEAR-OVER-YEAR SHAREHOLDERS APPROVE REDOMESTICATION TO THE U.S. COMPANY ANNOUNCES Q2 2023 QUARTERLY DIVIDEND AMSTERDAM , April 26, 2023 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2023 revenue of $128,400,000.

News for Core Laboratories Inc Stock (CLB)